|
Baseline characteristics
|
|
Age (years)
|
53.45 ± 9.50*
|
48.73 ± 10.67*
|
1.05 (1.02–1.09)*
|
50.98 ± 10.12**
|
49.63 ± 10.09**
|
1.01(0.98–1.05)**
|
53.68 ± 10.06*
|
46.04 ± 8.61*
|
1.09(1.05–1.13)*
|
|
Motivation
|
|
1–8
|
12 (26.1)**
|
34 (73.9)**
|
1.00**
|
15 (34.1)*
|
29 (65.9)*
|
1.00***
|
19 (45.2)**
|
23 (54.8)**
|
1.00**
|
|
9
|
9 (28.1)**
|
23 (71.9)**
|
1.11 (0.40–3.05)**
|
21 (65.6)*
|
11 (34.4)*
|
3.69 (1.41–9.64)*
|
18 (58.1)**
|
13 (41.9)**
|
1.68 (0.66–4.28)**
|
|
10
|
34 (38.2)***
|
55 (61.8)***
|
1.75 (0.80–3.84)***
|
59 (66.3)*
|
30 (33.7)*
|
3.80 (1.77–8.15)*
|
55 (62.5)**
|
33 (37.5)**
|
2.02 (0.96–4.25)**
|
|
Self-rated ability to do PFMT
|
|
1–9
|
25 (28.7)***
|
62 (71.3)***
|
1.00***
|
39 (45.9)*
|
46 (54.1)*
|
1.00*
|
40 (48.8)*
|
42 (51.2)*
|
1.00***
|
|
10
|
30 (37.5)***
|
50 (62.5)***
|
1.49 (0.78–2.85)***
|
56 (70.0)*
|
24 (30.0)*
|
2.75 (1.45–5.22)*
|
52 (65.8)*
|
27 (34.2)*
|
2.02 (1.07–3.82)*
|
|
Vaginal delivery >4,000 g
|
|
No
|
36 (34.6)**
|
68 (65.4)**
|
1.00**
|
64 (61.5)***
|
40 (38.5)***
|
1.00***
|
53 (52.5)***
|
48 (47.5)***
|
1.00***
|
|
Yes
|
13 (26.5)**
|
36 (73.5)**
|
0.68 (0.32–1.45)**
|
22 (46.8)***
|
25 (53.2)***
|
0.55 (0.27–1.10)***
|
29 (63.0)***
|
17 (37.0)***
|
1.55 (0.76–3.16)***
|
|
Menopause
|
|
No
|
26 (27.7)***
|
68 (72.3)***
|
1.00***
|
49 (53.8)**
|
42 (46.2)**
|
1.00**
|
39 (43.8)*
|
50 (56.2)*
|
1.00*
|
|
Yes
|
27 (39.1)***
|
42 (60.9)***
|
1.68 (0.87–3.26)***
|
42 (60.0)**
|
28 (40.0)**
|
1.29 (0.68–2.42)**
|
51 (75.0)*
|
17 (25.0)*
|
3.85 (1.93–7.67)*
|
|
Local estrogen
|
|
No
|
43 (29.9)*
|
101 (70.1)*
|
1.00*
|
79 (56.0)**
|
62 (44.0)**
|
1.00**
|
74 (53.6)*
|
64 (46.4)*
|
1.00*
|
|
Yes
|
11 (52.4)*
|
10 (47.6)*
|
2.58 (1.02–6.53)*
|
15 (68.2)**
|
7 (31.8)**
|
1.68 (0.65–4.38)**
|
17 (81.0)*
|
4 (19.9)*
|
3.68 (1.18–11.49)*
|
|
Moderate physical activity
|
|
< 3 h/week
|
23 (40.4)***
|
34 (59.6)***
|
1.00***
|
36 (63.2)*
|
21 (36.8)*
|
1.00*
|
33 (57.9)**
|
24 (42.1)**
|
1.00**
|
|
3–5 h/week
|
15 (27.8)***
|
39 (72.2)***
|
0.57 (0.26–1.26)***
|
23 (42.6)*
|
31 (57.4)*
|
0.43 (0.20–0.93)*
|
26 (51.0)**
|
25 (49.0)**
|
0.76 (0.35–1.62)**
|
|
>5 h/week
|
17 (29.8)***
|
40 (70.2)***
|
0.63 (0.29–1.37)***
|
36 (65.5)**
|
19 (34.5)**
|
1.11 (0.51–2.40)**
|
34 (63.0)**
|
20 (37.0)**
|
1.24 (0.58–2.65)**
|
|
Tea, cups/day
|
|
None
|
18 (34.0)**
|
35 (66.0)**
|
1.00**
|
33 (63.5)**
|
19 (36.5)**
|
1.00**
|
29 (56.9)***
|
22 (43.1)***
|
1.00***
|
|
1–2
|
24 (28.9)**
|
59 (71.1)**
|
0.79 (0.38–1.66)**
|
44 (53.0)***
|
39 (47.0)***
|
0.65 (0.32–1.32)***
|
43 (51.8)**
|
40 (48.2)**
|
0.82 (0.40–1.65)**
|
|
≥ 3
|
13 (40.6)**
|
19 (59.4)**
|
1.33 (0.54–3.29)**
|
18 (58.1)**
|
13 (41.9)**
|
0.80 (0.32–1.98)**
|
21 (75.0)***
|
7 (25.0)***
|
2.28 (0.82–6.31)***
|
|
ICIQ-UI SF
|
10.18 ± 3.37**
|
10.11 ± 3.13**
|
1.01 (0.91–1.11)**
|
11.51 ± 2.62*
|
8.35 ± 2.62*
|
1.49 (1.30–1.71)*
|
9.80 ± 3.45***
|
10.54 ± 2.88***
|
0.93 (0.84–1.03)***
|
|
ICIQ-LUTSqol
|
33.44 ± 8.40**
|
32.30 ± 5.85**
|
1.03 (0.98–1.07)**
|
34.49 ± 7.18*
|
30.48 ± 5.55*
|
1.11 (1.05–1.18)*
|
32.73 ± 7.63**
|
32.83 ± 5.79**
|
0.10 (0.95–1.04)**
|
|
4-month follow-up
|
|
PGI-I
|
|
Little better/much worse
|
21 (19.6)*
|
86 (80.4)*
|
1.00*
|
53 (49.5)*
|
54 (50.5)*
|
1.00*
|
46 (44.2)*
|
58 (55.8)*
|
1.00*
|
|
Much better/very much better
|
33 (55.0)*
|
27 (45.0)*
|
5.00 (2.49–10.05)*
|
41 (70.7)*
|
17 (29.3)*
|
2.46 (1.24–4.85)*
|
46 (80.0)*
|
11 (19.3)*
|
5.27 (2.46–11.31)*
|
|
MID ICIQ-UI SF
|
|
<3
|
18 (26.5)***
|
50 (73.5)***
|
1.00***
|
21 (31.3)*
|
46 (68.7)*
|
1.00*
|
32 (48.5)***
|
34 (51.5)***
|
1.00***
|
|
≥3
|
37 (37.4)***
|
62 (62.6)***
|
1.66 (0.84–3.26)***
|
73 (74.5)*
|
25 (25.5)*
|
6.40 (3.22–12.72)*
|
60 (63.2)***
|
35 (36.8)***
|
1.82 (0.96–3.45)***
|
|
MID ICIQ-LUTSqol
|
|
< 4
|
17 (23.3)*
|
56 (76.7)*
|
1.00*
|
30 (41.1)*
|
43 (58.9)*
|
1.00*
|
31 (43.7)*
|
40 (56.3)*
|
1.00*
|
|
≥ 4
|
37 (39.4)*
|
57 (60.6)*
|
2.14 (1.08–4.23)*
|
65 (69.9)*
|
28 (30.1)*
|
3.33 (1.75–6.33)*
|
62 (68.1)*
|
29 (31.9)*
|
2.76 (1.45–5.25)*
|
|
Sufficient treatment
|
|
No
|
13 (21.7)*
|
47 (78.3)*
|
1.00*
|
30 (50.8)***
|
29 (49.2)***
|
1.00***
|
16 (27.1)*
|
43 (72.9)*
|
1.00*
|
|
Yes
|
42 (40.0)*
|
63 (60.0)*
|
2.41 (1.16–4.99)*
|
63 (60.6)***
|
41 (39.4)***
|
1.49 (0.78–2.82)***
|
77 (76.2)*
|
24 (23.8)*
|
8.62 (4.14–17.97)*
|
|
1-year follow-up
|
|
PFMT last 3 months
|
|
Less than one time/week
|
30 (26.5)*
|
83 (73.5)*
|
1.00*
|
62 (54.9)**
|
51 (45.1)**
|
1.00**
|
53 (49.1)*
|
55 (50.9)*
|
1.00*
|
|
Regularly, at least one time/week
|
24 (45.3)*
|
29 (54.7)*
|
2.29 (1.16–4.53)*
|
33 (63.5)**
|
19 (36.5)**
|
1.43 (0.73–2.81)**
|
40 (75.5)*
|
13 (24.5)*
|
3.19 (1.54–6.63)*
|